Home-grown pharmaceutical companies in 2017 saw some erosion in their edge over multinational peers in the domestic drug market. Tempering the past year's trend of a significant lead, Indian drug firms grew at almost the same rate as their MNC counterparts. While Indian pharma players clocked a ...
Read more: Indian drug firms' growth slowed in 2017 on slow approvals, MNCs' caught up